Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,067 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,373
Recruiting: 799
Ph III recruiting: 82
Growth YoY: +14.4%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (618)

clinicaltrialsPublishedShowing 401–406 of 406 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04282044	Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies	recruiting	Phase 1	60	BioEclipse TherapeuticsINDUSTRY	1	Feb 8, 2024	clinicaltrials
NCT06195670	Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC	not yet recruiting	Phase 1 / Phase 2	220	Zhejiang Cancer HospitalOTHER	1	Jan 8, 2024